- Accesswire•18 days agoBlog Coverage Cumberland Pharma Bags Exclusive Rights for Europe Based Nordic Group Injectable Methotrexate Product Line for the US Market
Upcoming AWS Coverage on Depomed Post-Earnings Results LONDON, UK / ACCESSWIRE / November 17, 2016 / Active Wall St. blog coverage looks at the headline from Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ...
- PR Newswire•19 days ago
NASHVILLE, Tenn., Nov. 16, 2016 /PRNewswire/ -- Cumberland Pharmaceuticals (CPIX), a U.S. specialty pharmaceutical company has entered into an Agreement to acquire the exclusive U.S. rights to Nordic Group B.V.'s innovative injectable methotrexate product line. The products are designed for the treatment of active rheumatoid arthritis, juvenile idiopathic arthritis, severe psoriatic arthritis, and severe disabling psoriasis.
CPIX : Summary for Cumberland Pharmaceuticals Inc. - Yahoo Finance
Cumberland Pharmaceuticals Inc. (CPIX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||4.22 x 300|
|Ask||12.00 x 1200|
|Day's Range||5.46 - 5.59|
|52 Week Range||4.20 - 5.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1,850.00|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|